Polyrizon PLRZ
NASDAQ PLRZ
$10.30 -0.19 (-1.81%)
As of: Aug 21, 2026 · 3:34 PM EDT

Polyrizon (PLRZ) Goodwill & Intangibles (2024 - 2025)

Polyrizon's (PLRZ) quarterly Goodwill & Intangibles came in at $2.5 million in Q4 2025, down 11.69% YoY from $2.9 million in Q4 2024, and down 5.56% on a QoQ basis from $2.7 million in Q2 2025.

Polyrizon (PLRZ) Goodwill & Intangibles (2024 - 2025) Analysis & Trends

Polyrizon (PLRZ) has 2 years of Goodwill & Intangibles data on file, last reported at $2.5 million in Q4 2025.

  • Quarterly Goodwill & Intangibles fell 11.69% year-over-year to $2.5 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $2.5 million (down 11.69% YoY) and the FY2025 annual result came in at $2.5 million, down 11.69% from the prior year.
  • Goodwill & Intangibles retreated to $2.5 million in Q4 2025, from $2.7 million in the prior quarter.
  • In the past five years, Goodwill & Intangibles ranged from a high of $2.9 million in Q4 2024 to a low of $2.5 million in Q4 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 139.13 Bn 131.28 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 85.77 Bn 77.77 Bn 3.93 Bn
3 Argenx Se 64.64 Bn 59.46 Bn 1.37 Bn
4 Moderna 58.29 Bn 53.16 Bn 52.00 Mn
5 BeOne Medicines 41.92 Bn 36.82 Bn 1.53 Bn
6 Alnylam Pharmaceuticals 31.58 Bn 28.28 Bn 992.69 Mn
7 BioNTech SE 28.12 Bn 9.73 Bn 668.28 Mn
8 Insmed 27.39 Bn 26.22 Bn 358.27 Mn
9 Royalty Pharma 27.27 Bn 26.43 Bn -
10 Polyrizon 7.27 Mn -4.22 Mn -

Historic Data

Download Data
DateValue
Dec 31, 2025 2.55 Mn
Jun 30, 2025 2.70 Mn
Dec 31, 2024 2.88 Mn